Tweet tweet

We at __The Scientist__ are all a-flitter because we're now on Twitter. Starting this week, you can sign up to receive our "tweets" at twitter.com/TheScientistLLC. Twitter is a simple messaging service that allows users to share brief text updates -- otherwise known as tweets -- of up to 140 characters. (The last sentence was exactly 140 characters.) Readers can receive Twitter posts on the Web, on their mobile phones, via instant messaging, RSS feeds, Facebook, and various Twitter-dedicated ap

Written byElie Dolgin
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
We at __The Scientist__ are all a-flitter because we're now on Twitter. Starting this week, you can sign up to receive our "tweets" at twitter.com/TheScientistLLC. Twitter is a simple messaging service that allows users to share brief text updates -- otherwise known as tweets -- of up to 140 characters. (The last sentence was exactly 140 characters.) Readers can receive Twitter posts on the Web, on their mobile phones, via instant messaging, RSS feeds, Facebook, and various Twitter-dedicated applications.

__The Scientist__ plans to use this micro-blogging service to alert you of breaking stories as they happen. Why wait for tomorrow's daily e-mail when you can be alerted to the news right now? We also hope our Twitter hub will help readers stay connected, allowing you to let each other know what you're doing in the lab and elsewhere. Signing up is easy. Just go to our linkurl:Twitter site,;http://www.twitter.com/TheScientistLLC register for a new account if you don't already have one, and click on the "follow" button under the picture of the magazine cover. Alternatively, we also offer two basic RSS feeds: The linkurl:NewsBlog feed,;http://feeds.feedburner.com/TheScientistBlogs which posts all the latest news stories we write, and the linkurl:News feed,;http://feeds.feedburner.com/NewsFromTheScientist which tracks only what's sent in the daily email. Confused? Perplexed? Technophobic? Write to us with any questions at mail@the-scientist.com.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies